Heart Failure
Overview
Heart failure is a chronic clinical syndrome in which the heart cannot pump enough blood to meet the body’s needs or can do so only at elevated filling pressures. It does not mean the heart has stopped working; rather, it reflects impaired pumping, impaired filling, or both. Heart failure is commonly classified as heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF), and heart failure with mildly reduced ejection fraction (HFmrEF). Symptoms often include shortness of breath, fatigue, reduced exercise tolerance, swelling in the legs or abdomen, and fluid retention, although presentation can vary widely.
Heart failure is a major global public health issue associated with substantial morbidity, frequent hospitalization, reduced quality of life, and increased mortality. It often develops as the end result of other cardiovascular conditions, especially coronary artery disease, high blood pressure, heart valve disease, cardiomyopathies, diabetes, and arrhythmias. Population aging and improved survival after heart attacks have contributed to rising prevalence in many regions. Research from major cardiology organizations indicates that heart failure affects millions of adults worldwide and is one of the leading causes of hospital admission among older adults.
From a physiological standpoint, heart failure involves complex changes in the cardiovascular, renal, neurohormonal, and inflammatory systems. When cardiac output falls or filling pressures rise, the body activates compensatory mechanisms such as the renin-angiotensin-aldosterone system, the sympathetic nervous system, and fluid-retaining pathways. These responses may help in the short term but can worsen heart structure and function over time, contributing to ventricular remodeling, congestion, and progressive symptoms. Because of this complexity, heart failure is understood less as a single disease and more as a syndrome with multiple causes and pathways.
The condition also carries a significant personal and social burden. Many people with heart failure live with fluctuating symptoms, repeated care transitions, and coexisting illnesses such as kidney disease, sleep apnea, anemia, depression, or frailty. Early recognition, careful medical evaluation, and coordinated long-term management are considered central in conventional care. Complementary and traditional systems may frame heart failure differently, often emphasizing systemic imbalance, vitality, circulation, digestion, and fluid metabolism, but most responsible sources consider these approaches best interpreted as supportive rather than replacements for medical evaluation, particularly because worsening heart failure can become life-threatening.
Western Medicine Perspective
Western Medicine Perspective
In conventional medicine, heart failure is viewed as a syndrome with structural or functional impairment of ventricular filling or ejection of blood. Diagnosis typically draws on clinical history, physical examination, imaging, laboratory testing, and assessment of underlying causes. Common diagnostic tools include echocardiography to evaluate ejection fraction and valve function, natriuretic peptides such as BNP or NT-proBNP, electrocardiography, chest imaging, and tests for ischemia, arrhythmias, renal function, thyroid disease, iron status, and other contributing conditions. Contemporary guidelines also emphasize staging and functional classification, including the ACC/AHA stages and the New York Heart Association symptom classes.
Treatment in western medicine is generally aimed at several goals: improving symptoms, reducing hospitalization, slowing disease progression, and lowering mortality risk. Evidence-based care depends in part on the type of heart failure. For HFrEF, large clinical trials support the use of pharmacologic strategies such as angiotensin receptor-neprilysin inhibitors (or ACE inhibitors/ARBs in some settings), beta blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. Additional therapies may include diuretics for congestion, hydralazine/isosorbide dinitrate in selected populations, anticoagulation when indicated, iron repletion in certain cases, and management of comorbidities. Device-based therapies such as implantable cardioverter-defibrillators, cardiac resynchronization therapy, ventricular assist devices, and in advanced cases heart transplantation may be considered in appropriate clinical contexts.
For HFpEF, management has historically been more challenging because fewer therapies have shown broad mortality benefit, though studies indicate that SGLT2 inhibitors can reduce heart failure hospitalization in many patients. Conventional care also focuses heavily on managing blood pressure, atrial fibrillation, ischemic heart disease, obesity, diabetes, kidney disease, and volume status. Across all types of heart failure, clinicians monitor for decompensation, emphasize individualized risk stratification, and often incorporate cardiac rehabilitation, nutrition counseling, physical activity guidance, and palliative/supportive care when appropriate. Because symptoms such as sudden weight gain, worsening shortness of breath, chest pain, confusion, or fainting can indicate urgent deterioration, western medicine treats heart failure as a condition requiring ongoing professional follow-up.
Eastern & Traditional Perspective
Eastern and Traditional Medicine Perspective
In Traditional Chinese Medicine (TCM), heart failure is not defined by ejection fraction or ventricular mechanics but is interpreted through patterns of disharmony involving the Heart, Lung, Spleen, and Kidney systems, as well as disturbances of Qi, Blood, Yin, Yang, and body fluids. Symptoms such as palpitations, edema, shortness of breath, fatigue, and cold extremities may be understood in pattern terms such as Heart Qi deficiency, Heart Yang deficiency, Kidney Yang deficiency, Blood stasis, or phlegm-fluid retention. Traditional assessment relies on symptom patterns, pulse, tongue findings, and constitutional factors. TCM literature has historically described treatment principles such as supporting Heart Qi, warming Yang, transforming phlegm, promoting urination, and moving Blood, often using individualized herbal formulas and acupuncture.
In Ayurveda, heart-related weakness may be interpreted through imbalances in doshas, especially disturbances involving Vata and Kapha, impaired circulation, fluid accumulation, weakened digestive/metabolic fire (agni), and reduced tissue vitality (ojas). Classical and contemporary Ayurvedic practitioners may discuss the condition in relation to disorders of the hridaya (heart), channels of circulation, and systemic congestion. Traditional approaches often emphasize constitutional assessment, digestion, fluid balance, restorative routines, botanical formulations, and mind-body practices, though these frameworks differ substantially from biomedical cardiology.
Naturopathic and integrative medicine perspectives often focus on the broader terrain surrounding heart failure: inflammation, oxidative stress, mitochondrial function, sleep quality, stress burden, metabolic disease, and nutrition status. Some complementary modalities—such as gentle mind-body practices, supervised rehabilitation-style exercise, stress reduction, and selected adjunctive therapies—have been explored for quality of life or symptom burden. However, evidence for many herbs and supplements in heart failure remains limited, mixed, or safety-sensitive, especially because some natural products may interact with cardiac medications, affect fluid balance, blood pressure, rhythm, or kidney function.
Across traditional systems, a recurring theme is that heart failure reflects a deeper systemic imbalance rather than an isolated organ problem. At the same time, most evidence-informed integrative sources stress that significant shortness of breath, edema, exercise intolerance, or signs of fluid overload warrant conventional medical assessment. Traditional therapies are generally discussed as complementary frameworks for supporting well-being, symptom interpretation, and holistic care, rather than substitutes for diagnosis and monitoring in a potentially serious cardiovascular condition.
Related Topics
Beta Blockers
Beta Blockers — a treatment in the health ontology.
How They Relate
Heart Failure & Beta Blockers
Heart failure (HF) is a clinical syndrome in which the heart cannot meet the body’s metabolic needs. Two broad phenotypes are recognized: heart failure with reduced ejection fraction (HFrEF, typica...
Evidence & Sources
Supported by multiple clinical trials and systematic reviews
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure
- New England Journal of Medicine
- Journal of the American College of Cardiology
- Circulation
- The Lancet
- National Heart, Lung, and Blood Institute (NHLBI)
- National Center for Complementary and Integrative Health (NCCIH)
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.